Advocate Educate, empower and support In keeping with our mission to educate, empower and support individuals and communities in the prevention and treatment of osteoporosis, Osteoporosis Canada communicates concerns about various […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

SAC Newsletter SAC Link The SAC Link is a quarterly newsletter for members of Osteoporosis Canada’s Scientific Advisory Council. It includes Osteoporosis Canada news, updates from committees and member news. […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

Dr. Mohit Bhandari, a member of the SAC Executive committee,  a Professor in the Department of Surgery at McMaster University and a leader in the field of orthopedic surgery has […]

Latest News CIHR Institute of Aging Award Winners for 2022-2023 November 7, 2023 Congratulations to Dr. Alexandra Papaioannou, member of the Osteoporosis Canada Scientific Advisory Council (SAC) is one of […]

Available Volunteer Opportunities Call for Nominations – Board of Directors After evaluating the strengths of the existing Board of Directors, the Board Development Committee is seeking individuals with the following […]

Latest News Dr. Angela Man-Wei Cheung ISCD 2024 Board Announcement April  19, 2024 The International Society for Clinical Densitometry (ISCD) is the leading membership organization for professionals working to assess, […]

Our Leadership Our Senior Team Meet the members of the Senior Team at Osteoporosis Canada who are committed and passionate about their work in creating a Canada without osteoporotic fractures […]